Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.

During the past decade, Rabin MC; Davidof Center - Oncology Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rabin MC; Davidof Center - Oncology Institute" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "BioLineRx, Ltd." with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Rabin MC; Davidof Center - Oncology Institute" are "Breast Cancer" (3 trials), "Solid Tumors" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Cancer of Unknown Primary Site" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Rabin MC; Davidof Center - Oncology Institute" in a lesser frequency.

Most popular intervention types in "Rabin MC; Davidof Center - Oncology Institute" are "Drug" (14 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Paclitaxel" (5 trials), "Bevacizumab" (4 trials), "Cobimetinib" (4 trials) and "Ipatasertib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Rabin MC; Davidof Center - Oncology Institute" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rabin MC; Davidof Center - Oncology Institute". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rabin MC; Davidof Center - Oncology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rabin MC; Davidof Center - Oncology Institute, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".